IDEXX Laboratories, Inc.
IDXXNASDAQHealthcare● Active
$561.17
$-0.99(-0.18%)
Market Cap$44.3B
P/E Ratio—
52W High$769.98
52W Low$506.91
IDEXX Laboratories, Inc. (IDXX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
IDXX · earnings · updated Jun 10, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
$3.47
Est. $3.41 · +1.8%
Revenue
$1.14B
Est. $1.12B · +2.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 11-Quarter EPS Beat Streak
IDXX reports quarterly as a NASDAQ-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Next earnings date not yet announced.
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 3, 2026 | $3.95 | — | — | — | $1.20B | — |
| ▲ Q2 FY2026 | May 5, 2026 | $3.41 | $3.47 | +1.8% | $1.14B | $1.12B | +2.0% |
| ▲ Q1 FY2026 | Feb 2, 2026 | $2.93 | $3.08 | +5.1% | $1.09B | $1.07B | +1.7% |
| ▲ Q4 FY2025 | Nov 3, 2025 | $3.14 | $3.40 | +8.3% | $1.11B | $1.07B | +3.0% |
| ▲ Q3 FY2025 | Aug 4, 2025 | $3.28 | $3.63 | +10.7% | $1.11B | $1.06B | +4.4% |
| ▲ Q2 FY2025 | May 1, 2025 | $2.85 | $2.96 | +3.9% | $1.00B | $1.00B | +0.1% |
| ▲ Q1 FY2025 | Feb 3, 2025 | $2.39 | $2.62 | +9.6% | $0.95B | $0.94B | +2.0% |
| ▲ Q4 FY2024 | Oct 31, 2024 | $2.68 | $2.80 | +4.5% | $0.98B | $0.98B | -0.5% |
Q3 FY2026
Aug 3, 2026
EPS Actual
—
EPS Est.
$3.95
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 5, 2026Beat
EPS Actual
$3.47
EPS Est.
$3.41
EPS Surpr.
+1.8%
Revenue
$1.14B
Q1 FY2026
Feb 2, 2026Beat
EPS Actual
$3.08
EPS Est.
$2.93
EPS Surpr.
+5.1%
Revenue
$1.09B
Q4 FY2025
Nov 3, 2025Beat
EPS Actual
$3.40
EPS Est.
$3.14
EPS Surpr.
+8.3%
Revenue
$1.11B
Q3 FY2025
Aug 4, 2025Beat
EPS Actual
$3.63
EPS Est.
$3.28
EPS Surpr.
+10.7%
Revenue
$1.11B
Q2 FY2025
May 1, 2025Beat
EPS Actual
$2.96
EPS Est.
$2.85
EPS Surpr.
+3.9%
Revenue
$1.00B
Q1 FY2025
Feb 3, 2025Beat
EPS Actual
$2.62
EPS Est.
$2.39
EPS Surpr.
+9.6%
Revenue
$0.95B
Q4 FY2024
Oct 31, 2024Beat
EPS Actual
$2.80
EPS Est.
$2.68
EPS Surpr.
+4.5%
Revenue
$0.98B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2029 | $4.53 | $4.57 | $4.61 | 3 |
| Q4 FY2028 | $4.43 | $4.47 | $4.51 | 7 |
| Q3 FY2028 | $4.78 | $4.83 | $4.88 | 4 |
| Q2 FY2028 | $5.05 | $5.10 | $5.14 | 6 |
| Q1 FY2028 | $4.32 | $4.36 | $4.40 | 4 |
| Q4 FY2027 | $3.89 | $3.92 | $3.96 | 6 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2029 | $1.4B | $1.4B | $1.4B | 4 |
| Q4 FY2028 | $1.4B | $1.4B | $1.4B | 6 |
| Q3 FY2028 | $1.4B | $1.4B | $1.4B | 3 |
| Q2 FY2028 | $1.4B | $1.4B | $1.4B | 5 |
| Q1 FY2028 | $1.3B | $1.3B | $1.3B | 3 |
| Q4 FY2027 | $1.3B | $1.3B | $1.3B | 7 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 5, 2026 | +1.8% | $563.12 | $562.97 | -0.03% |
| ▲ Q1 FY2026 | Feb 2, 2026 | +5.1% | $670.46 | $639.60 | -4.60% |
| ▲ Q4 FY2025 | Nov 3, 2025 | +8.3% | $629.51 | $722.94 | +14.84% |
| ▲ Q3 FY2025 | Aug 4, 2025 | +10.7% | $535.54 | $682.78 | +27.49% |
| ▲ Q2 FY2025 | May 1, 2025 | +3.9% | $432.65 | $471.38 | +8.95% |
| ▲ Q1 FY2025 | Feb 3, 2025 | +9.6% | $422.05 | $469.04 | +11.13% |
| ▲ Q4 FY2024 | Oct 31, 2024 | +4.5% | $451.08 | $406.92 | -9.79% |
| ▲ Q3 FY2024 | Aug 6, 2024 | +4.9% | $455.08 | $469.37 | +3.14% |
Q2 FY2026-0.03%
Report Date
May 5, 2026
EPS Beat/Miss
+1.8%
Price Before
$563.12
Price After
$562.97
Q1 FY2026-4.60%
Report Date
Feb 2, 2026
EPS Beat/Miss
+5.1%
Price Before
$670.46
Price After
$639.60
Q4 FY2025+14.84%
Report Date
Nov 3, 2025
EPS Beat/Miss
+8.3%
Price Before
$629.51
Price After
$722.94
Q3 FY2025+27.49%
Report Date
Aug 4, 2025
EPS Beat/Miss
+10.7%
Price Before
$535.54
Price After
$682.78
Q2 FY2025+8.95%
Report Date
May 1, 2025
EPS Beat/Miss
+3.9%
Price Before
$432.65
Price After
$471.38
Q1 FY2025+11.13%
Report Date
Feb 3, 2025
EPS Beat/Miss
+9.6%
Price Before
$422.05
Price After
$469.04
Q4 FY2024-9.79%
Report Date
Oct 31, 2024
EPS Beat/Miss
+4.5%
Price Before
$451.08
Price After
$406.92
Q3 FY2024+3.14%
Report Date
Aug 6, 2024
EPS Beat/Miss
+4.9%
Price Before
$455.08
Price After
$469.37
Avg Beat Reaction+6.39%
Beat Rate8 / 8 quarters
Largest Move+27.49% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: IDXX ends December
IDEXX Laboratories, Inc. (IDXX) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $3.47 — beating the analyst consensus of $3.41 by +1.8%. IDXX has beaten EPS estimates for 11 consecutive quarters.
Each quarter, investors track IDXX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. IDXX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
IDXX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
IDXX earnings · 5 questionsIDEXX Laboratories, Inc.'s next earnings report is expected around TBD. IDXX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; IDXX historically reports after market close (AMC).
IDXX earnings datewhen is IDXX earningsIDXX next earnings datewhen does IDXX report earningsIDXX earnings calendar
▸ Source: FMP · IDEXX Laboratories, Inc. SEC filings · US GAAP · IDEXX Laboratories, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026